Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Gastroparesis Drug Market Report. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Gastroparesis Drug Trends and Forecast

The future of the global gastroparesis drug market looks promising with opportunities in the diabetic gastroparesis, idiopathic gastroparesis, and post-surgical gastroparesis markets. The global gastroparesis drug market is expected to grow with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are increase in number of surgeries, rising incidence rate of the diabetic population, and launch of innovative medications designed to manage symptoms like nausea and vomiting.
Gastroparesis Drug Trends and Forecast

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Gastroparesis Drug by Segment

Gastroparesis Drug by Segment

The study includes a forecast for the global gastroparesis drug by drug class, disease type, distribution channel, and region.

Gastroparesis Drug Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:


• Prokinetic Agents
• Antiemetic Agents
• Botulinum Toxin Injections

• Diabetic Gastroparesis
• Idiopathic Gastroparesis
• Post-Surgical Gastroparesis
• Others

Gastroparesis Drug Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:


• Hospitals
• Pharmacies
• Clinics
• e-Commerce

Gastroparesis Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:


• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Gastroparesis Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies gastroparesis drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the gastroparesis drug companies profiled in this report include-
• Allergan
• Abbott Laboratories
• AstraZeneca
• Cadila Pharmaceuticals
• ETX Pharma
• Evoke Pharma
• GlaxoSmithKline

Gastroparesis Drug Market Insights

Lucintel forecasts that antiemetic agents is expected to witness the highest growth over the forecast period.
Within this market, idiopathic gastroparesis will remain the largest segment.
North America is expected to witness highest growth over the forecast period due to surge in aging population, along with an increasing number of surgical procedures.

Features of the Global Gastroparesis Drug Market

Market Size Estimates: Gastroparesis drug market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Gastroparesis drug market size by drug class, disease type, distribution channel, and region in terms of value ($B).
Regional Analysis: Gastroparesis drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug classes, disease types, distribution channels, and regions for the gastroparesis drug market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the gastroparesis drug market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the growth forecast for gastroparesis drug market?
Answer: The global gastroparesis drug market is expected to grow with a CAGR of 4.5% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the gastroparesis drug market?
Answer: The major drivers for this market are increase in number of surgeries, rising incidence rate of the diabetic population and launch of innovative medications designed to manage symptoms like nausea and vomiting.
Q3. What are the major segments for gastroparesis drug market?
Answer: The future of the gastroparesis drug market looks promising with opportunities in the diabetic gastroparesis, idiopathic gastroparesis, and post-surgical gastroparesis markets.
Q4. Who are the key gastroparesis drug market companies?
Answer: Some of the key gastroparesis drug companies are as follows:
• Allergan
• Abbott Laboratories
• AstraZeneca
• Cadila Pharmaceuticals
• ETX Pharma
• Evoke Pharma
• GlaxoSmithKline
Q5. Which gastroparesis drug market segment will be the largest in future?
Answer: Lucintel forecasts that antiemetic agents is expected to witness the highest growth over the forecast period.
Q6. In gastroparesis drug market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to surge in aging population, along with an increasing number of surgical procedures.
Q.7 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the gastroparesis drug market by drug class (prokinetic agents, antiemetic agents, and botulinum toxin injections), disease type (diabetic gastroparesis, idiopathic gastroparesis, post-surgical gastroparesis, and others), distribution channel (hospitals, pharmacies, clinics, and e-commerce), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to Gastroparesis Drug Market, Gastroparesis Drug Market Size, Gastroparesis Drug Market Growth, Gastroparesis Drug Market Analysis, Gastroparesis Drug Market Report, Gastroparesis Drug Market Share, Gastroparesis Drug Market Trends, Gastroparesis Drug Market Forecast, Gastroparesis Drug Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents

1. Executive Summary
2. Global Gastroparesis Drug Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Gastroparesis Drug Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Gastroparesis Drug Market by Drug Class
3.3.1: Prokinetic Agents
3.3.2: Antiemetic Agents
3.3.3: Botulinum Toxin Injections
3.4: Global Gastroparesis Drug Market by Disease Type
3.4.1: Diabetic Gastroparesis
3.4.2: Idiopathic Gastroparesis
3.4.3: Post-surgical Gastroparesis
3.4.4: Others
3.5: Global Gastroparesis Drug Market by Distribution Channel
3.5.1: Hospitals
3.5.2: Pharmacies
3.5.3: Clinics
3.5.4: e-commerce
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Gastroparesis Drug Market by Region
4.2: North American Gastroparesis Drug Market
4.2.1: North American Gastroparesis Drug Market by Drug Class: Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections
4.2.2: North American Gastroparesis Drug Market by Disease Type: Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, and Others
4.3: European Gastroparesis Drug Market
4.3.1: European Gastroparesis Drug Market by Drug Class: Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections
4.3.2: European Gastroparesis Drug Market by Disease Type: Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, and Others
4.4: APAC Gastroparesis Drug Market
4.4.1: APAC Gastroparesis Drug Market by Drug Class: Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections
4.4.2: APAC Gastroparesis Drug Market by Disease Type: Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, and Others
4.5: ROW Gastroparesis Drug Market
4.5.1: ROW Gastroparesis Drug Market by Drug Class: Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections
4.5.2: ROW Gastroparesis Drug Market by Disease Type: Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Gastroparesis Drug Market by Drug Class
6.1.2: Growth Opportunities for the Global Gastroparesis Drug Market by Disease Type
6.1.3: Growth Opportunities for the Global Gastroparesis Drug Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Gastroparesis Drug Market by Region
6.2: Emerging Trends in the Global Gastroparesis Drug Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Gastroparesis Drug Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Gastroparesis Drug Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Allergan
7.2: Abbott Laboratories
7.3: AstraZeneca
7.4: Cadila Pharmaceuticals
7.5: ETX Pharma
7.6: Evoke Pharma
7.7: GlaxoSmithKline
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Gastroparesis Drug Market Report: Trends, Forecast and Competitive Analysis to 2030 Full Report $ 4,850
A 150 Page Report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.